logo

Fate Therapeutics, Inc (FATE)



Trade FATE now with
  Date
  Headline
3/1/2022 5:00:55 PM Wedbush Is Lowering Fate Therapeutics, Inc (FATE) FY22 Estimate To -3.49 From -2.86
3/1/2022 5:00:39 PM Wedbush Is Lowering Fate Therapeutics, Inc (FATE) Q4 22 Estimate To -0.89 From -0.73
3/1/2022 5:00:29 PM Wedbush Is Lowering Fate Therapeutics, Inc (FATE) Q3 22 Estimate To -0.86 From -0.71
3/1/2022 5:00:08 PM Wedbush Is Cutting Fate Therapeutics, Inc (FATE) Q2 22 Estimate To -0.89 From -0.73
3/1/2022 4:59:54 PM Wedbush Is Cutting Fate Therapeutics, Inc (FATE) Q1 22 Estimate To -0.85 From -0.70
3/1/2022 4:59:25 PM Wedbush Reiterates Fate Therapeutics, Inc (FATE) At Outperform With $77 Up From $74 Price Target
12/15/2021 4:19:20 PM Wedbush Ups Fate Therapeutics, Inc (FATE) To Outperform From Neutral With $74 Up From $71 Price Target
6/4/2021 7:14:17 AM Fate Therapeutics Highlights Positive Interim Data From FT516 Phase 1 Study With Rituximab For B-cell Lymphoma At ASCO
3/6/2019 9:02:44 AM Wedbush Reiterates Fate Therapeutics, Inc (FATE) At Outperform With $21 Price Target
2/11/2019 6:59:03 AM Wedbush Is Increasing Fate Therapeutics, Inc (FATE) FY18 Estimate To -1.05 From -1.07
2/11/2019 6:58:38 AM Wedbush Is Raising Fate Therapeutics, Inc (FATE) Q4 18 Estimate To -0.10 From -0.12
2/11/2019 6:57:33 AM Wedbush Reiterates Fate Therapeutics, Inc (FATE) At Outperform With $21 Up From $19 Price Target
11/2/2018 9:08:47 AM Wedbush Is Lowering Fate Therapeutics, Inc (FATE) FY18 Estimate To -1.07 From -1.01
11/2/2018 9:08:30 AM Wedbush Is Raising Fate Therapeutics, Inc (FATE) Q4 18 Estimate To -0.12 From -0.27
9/19/2018 6:40:19 AM Wedbush Is Raising Fate Therapeutics, Inc (FATE) FY18 Rev. Estimate To 14.1 M From 5.2 M
9/19/2018 6:39:45 AM Wedbush Is Raising Fate Therapeutics, Inc (FATE) FY18 Estimate To -1.01 From -1.17
9/19/2018 6:39:27 AM Wedbush Is Raising Fate Therapeutics, Inc (FATE) Q3 18 Estimate To -0.10 From -0.27
9/19/2018 6:39:04 AM Wedbush Reiterates Fate Therapeutics, Inc (FATE) At Outperform With $19 Price Target
8/7/2018 8:18:29 AM Wedbush Is Lowering Fate Therapeutics, Inc (FATE) FY18 Estimate To -1.17 From -0.99
8/7/2018 8:18:17 AM Wedbush Is Cutting Fate Therapeutics, Inc (FATE) Q4 18 Estimate To -0.27 From -0.22